TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) Operating Profit

Annual Operating Profit:

-$120.57M+$22.59M(+15.78%)
December 31, 2024

Summary

  • As of today, TARS annual operating income is -$120.57 million, with the most recent change of +$22.59 million (+15.78%) on December 31, 2024.
  • During the last 3 years, TARS annual operating profit has fallen by -$108.41 million (-891.77%).
  • TARS annual operating profit is now -8831.04% below its all-time high of -$1.35 million, reached on December 31, 2018.

Performance

TARS Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Quarterly Operating Profit:

-$22.18M+$4.10M(+15.59%)
June 30, 2025

Summary

  • As of today, TARS quarterly operating income is -$22.18 million, with the most recent change of +$4.10 million (+15.59%) on June 30, 2025.
  • Over the past year, TARS quarterly operating profit has increased by +$11.12 million (+33.39%).
  • TARS quarterly operating profit is now -307.06% below its all-time high of $10.71 million, reached on March 31, 2021.

Performance

TARS Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

TTM Operating Profit:

-$98.05M+$11.12M(+10.18%)
June 30, 2025

Summary

  • As of today, TARS TTM operating income is -$98.05 million, with the most recent change of +$11.12 million (+10.18%) on June 30, 2025.
  • Over the past year, TARS TTM operating profit has increased by +$58.32 million (+37.30%).
  • TARS TTM operating profit is now -15389.26% below its all-time high of -$633.00 thousand, reached on September 30, 2019.

Performance

TARS TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

TARS Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+15.8%+33.4%+37.3%
3Y3 Years-891.8%-324.7%-78.6%
5Y5 Years-2705.2%-579.9%-490.4%

TARS Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-891.8%+15.8%-47.3%+50.1%-57.9%+37.3%
5Y5-Year-2705.2%+15.8%-307.1%+50.1%-2607.0%+37.3%
All-TimeAll-Time-8831.0%+15.8%-307.1%+50.1%>-9999.0%+37.3%

TARS Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$22.18M(+15.6%)
-$98.05M(+10.2%)
Mar 2025
-
-$26.28M(-7.6%)
-$109.17M(+9.5%)
Dec 2024
-$120.57M(+15.8%)
-$24.42M(+2.9%)
-$120.57M(+14.2%)
Sep 2024
-
-$25.16M(+24.4%)
-$140.60M(+10.1%)
Jun 2024
-
-$33.30M(+11.6%)
-$156.37M(-0.3%)
Mar 2024
-
-$37.68M(+15.2%)
-$155.89M(-8.9%)
Dec 2023
-$143.16M(-128.3%)
-$44.45M(-8.6%)
-$143.16M(-25.8%)
Sep 2023
-
-$40.94M(-24.7%)
-$113.77M(-18.8%)
Jun 2023
-
-$32.82M(-31.5%)
-$95.74M(-40.5%)
Mar 2023
-
-$24.95M(-65.7%)
-$68.14M(-8.7%)
Dec 2022
-$62.71M
-$15.06M(+34.2%)
-$62.71M(-1.0%)
Sep 2022
-
-$22.91M(-338.5%)
-$62.10M(-13.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$5.22M(+73.2%)
-$54.90M(-29.5%)
Mar 2022
-
-$19.52M(-35.1%)
-$42.39M(-248.7%)
Dec 2021
-$12.16M(+55.0%)
-$14.45M(+8.0%)
-$12.16M(-32.3%)
Sep 2021
-
-$15.71M(-315.7%)
-$9.19M(-153.6%)
Jun 2021
-
$7.28M(-32.0%)
-$3.62M(+74.4%)
Mar 2021
-
$10.71M(+193.4%)
-$14.17M(+47.5%)
Dec 2020
-$27.00M(-528.2%)
-$11.48M(-13.2%)
-$27.00M(-62.6%)
Sep 2020
-
-$10.14M(-210.8%)
-$16.61M(-134.0%)
Jun 2020
-
-$3.26M(-54.1%)
-$7.10M(-85.1%)
Mar 2020
-
-$2.12M(-95.4%)
-$3.83M(-123.4%)
Dec 2019
-$4.30M(-218.4%)
-$1.08M(-71.2%)
-$1.72M(-171.2%)
Sep 2019
-
-$633.00K
-$633.00K
Dec 2018
-$1.35M
-
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of TARS is -$120.57M

What is the all-time high annual operating profit for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual operating income is -$1.35M

What is Tarsus Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, TARS annual operating income has changed by +$22.59M (+15.78%)

What is Tarsus Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of TARS is -$22.18M

What is the all-time high quarterly operating profit for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly operating income is $10.71M

What is Tarsus Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, TARS quarterly operating income has changed by +$11.12M (+33.39%)

What is Tarsus Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of TARS is -$98.05M

What is the all-time high TTM operating profit for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high TTM operating income is -$633.00K

What is Tarsus Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, TARS TTM operating income has changed by +$58.32M (+37.30%)
On this page